Cleared Traditional

K243697 - MySpine WebPlanner

K243697 is the FDA 510(k) clearance for MySpine WebPlanner by Medacta International S.A.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K243697 · Medacta International S.A. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
145d
Days
Class 2
Risk

K243697 is an FDA 510(k) clearance for the MySpine WebPlanner. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Medacta International S.A. (Castel San Pietro, CH). The FDA issued a Cleared decision on April 23, 2025 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Medacta International S.A. devices

Submission Details

510(k) Number K243697 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 29, 2024
Decision Date April 23, 2025
Days to Decision 145 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
38d slower than avg
Panel avg: 107d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Medacta USA
Christoper Lussier

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1056
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K243697.
SMARTDent
K251109 · Ray Co., Ltd. · May 2025
uWS-Angio Basic
K243632 · Shanghai United Imaging Healthcare Co., Ltd. · May 2025
LUMYS (V1)
K243069 · Intradys · May 2025
VersaViewer
K243651 · GE Medical Systems SCS · Apr 2025
MySegmenter (v2.0.0)
K242647 · Mysegmenter Technologies, Inc. · Apr 2025
Merge Universal Viewer (MUV)
K250301 · Merge Healthcare Incorporated · Apr 2025